BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18816787)

  • 1. What is the role of serological markers in the diagnosis of IBD?
    Dubinsky MC
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S185-6. PubMed ID: 18816787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological markers in inflammatory bowel disease: practical consideration for clinicians.
    Mendoza JL; Abreu MT
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S158-73. PubMed ID: 20117339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of serological markers in inflammatory bowel diseases: gadget or magic?
    Papp M; Norman GL; Altorjay I; Lakatos PL
    World J Gastroenterol; 2007 Apr; 13(14):2028-36. PubMed ID: 17465443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of serological and genetic markers in inflammatory bowel disease; strength and weakness of the studies.
    Peña AS
    Rev Esp Enferm Dig; 2003 Nov; 95(11):752-4, 749-51. PubMed ID: 14640872
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease.
    Mancho C; Sainz A; García-Sancho M; Villaescusa A; Tesouro MA; Rodríguez-Franco F
    J Vet Diagn Invest; 2010 Jul; 22(4):553-8. PubMed ID: 20622225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.
    Iborra M; Beltrán B; Nos P
    Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):641-56. PubMed ID: 27633593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory bowel diseases and Takayasu's arteritis: coincidence or association?
    Kilic L; Kalyoncu U; Karadag O; Akdogan A; Dogan I; Bilgen SA; Kiraz S; Ertenli I
    Int J Rheum Dis; 2016 Aug; 19(8):814-8. PubMed ID: 26913584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
    Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G
    Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody markers in the diagnosis of inflammatory bowel disease.
    Mitsuyama K; Niwa M; Takedatsu H; Yamasaki H; Kuwaki K; Yoshioka S; Yamauchi R; Fukunaga S; Torimura T
    World J Gastroenterol; 2016 Jan; 22(3):1304-10. PubMed ID: 26811667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological diagnosis of inflammatory bowel disease.
    Rutgeerts P; Vermeire S
    Lancet; 2000 Dec 23-30; 356(9248):2117-8. PubMed ID: 11191535
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic Modalities for Inflammatory Bowel Disease: Serologic Markers and Endoscopy.
    Clark C; Turner J
    Surg Clin North Am; 2015 Dec; 95(6):1123-41, v. PubMed ID: 26596918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The promise and pitfalls of serologic testing in inflammatory bowel disease.
    Sellin JH; Shah RR
    Gastroenterol Clin North Am; 2012 Jun; 41(2):463-82. PubMed ID: 22500529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of autoantibodies in inflammatory bowel disease.
    Herszényi L; Tulassay Z
    Dig Dis; 2012; 30(2):201-7. PubMed ID: 22722439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of serologic markers in a population-based Norwegian cohort with inflammatory bowel disease.
    Solberg IC; Lygren I; Cvancarova M; Jahnsen J; Stray N; Sauar J; Schreiber S; Moum B; Vatn MH;
    Inflamm Bowel Dis; 2009 Mar; 15(3):406-14. PubMed ID: 19009607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic markers in inflammatory bowel disease (IBD).
    Nakamura RM; Barry M
    MLO Med Lab Obs; 2001 Nov; 33(11):8-15; quiz 16-9. PubMed ID: 11721286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of serological assays in pediatric inflammatory bowel disorders.
    Mainardi E; Villanacci V; Bassotti G; Liserre B; Rossi E; Incardona P; Falchetti D; Tonegatti L; Montanelli A; Barabino A; Coccia C; Gambini C
    Digestion; 2007; 75(4):210-4. PubMed ID: 17952008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relevance of serologic studies in inflammatory bowel diseases].
    Papp M; Altorjay I; Lakatos PL
    Orv Hetil; 2007 May; 148(19):887-96. PubMed ID: 17478404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
    Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serologic disease markers in inflammatory bowel disease].
    Domènech Morral E
    Med Clin (Barc); 2004 Feb; 122(4):138-9. PubMed ID: 14967096
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.